Market Entry - Active Pharmaceutical Ingredients (API) Industry in China: Analysis of Growth, Trends and Progress (2016 - 2021)

Market Entry - Active Pharmaceutical Ingredients (API) Industry in China: Analysis of Growth, Trends and Progress (2016 - 2021)

Purchase Report

About the Market

The API market is surging due to the increased demand for pharmaceutical drugs, which in turn is driven by the aging population, rising prevalence of chronic diseases such as cancer, diabetes, cardiovascular, neurological and infectious diseases. India and China are the major suppliers of APIs to North America due to their low production capacities, labor costs and the presence of a large number of global and domestic players. In order to cut down on expenses and increase profits, companies have begun outsourcing the creation of APIs to the developing countries in Asia, leading to growth in the Asian market. The safety of medication APIs are subject to stringent regulations and oversight from the country they are shipped to. Teva Pharmaceuticals Limited, Sun Pharmaceuticals Industries Limited, Dr. Reddy’s Laboratories Ltd., and Aurobindo are some key players in the market.

About the Geography

China, a USD 10 trillion economy with a strong communist government at its helm, is reshaping the global economy, like never before.  China is the world’s second largest market and is continually growing to become an attractive destination for foreign investment.

Since the late 1970s, China has moved from being a closed economy to a more market-oriented one. In the past 30 years, the Chinese government has at times opened the door wide for foreign companies while keeping it firmly closed in sectors where the government seeks to develop domestic firms into international giants. The government of China discourages investments, which intend to profit from speculation like currency and real estate. The government has also indicated that it plans to restrict foreign investment in resource intensive and highly polluting industries. Policy changes to RMB Qualified Foreign Institutional Investors (RQFII) were introduced in March 2013, which have loosened market entry requirements for registered financial institutions.

Large parts of the economy are still closed to foreign firms and there is a strong competition from state-owned industries in the remaining sectors. The country is also well-known for its tangled bureaucratic web, which along with the complex business structure and language barrier, can make doing business in China a bit tough. However, with 1.3 billion internal consumers and a rapidly growing market, China offers an endless array of opportunities for firms from across the globe.

 

Component Name

Unit

From Site

                                               GDP             

USD billion

10866

GDP Annual Growth Rate

%

6.7

GDP Per Capita

USD

6416

Unemployment Rate

%

4.05

Wages

USD/Year

9,207.37

Inflation Rate

%

1.9

Consumer Price Index (CPI)

Index Points

102

Interest Rate

%

4.35

Business Confidence

(No Units)

50.4

Manufacturing PMI

Index Points

50.1

Ease of Doing Business

(No Units)

84

Competitiveness Rank

(No Units)

28

Corruption Rank

(No Units)

83

Consumer Confidence

(No Units)

106

Bank Lending Rate (Consumers)

%

4.35

Corporate Tax Rate

%

25

Sales Tax Rate

%

17

 

The Market Entry Series

Exploring global markets is now recognized as the shortest way to ensure high time to efficiency conversion, when trying to expand revenues past domestic markets, for firms both large and small. Our market entry series, priced suitably low contains the essentials of all the parameters (Refer: Table of Contents) you must be apprised of before you can have a well informed contemplation of a business opportunity in your choice of industry, in your choice of geography.

1. Introduction

                1.1 Scope of the Report

                1.2 Regional Analysis

                                1.2.1 PESTLE Analysis

                                1.2.2 Analysis of Ease of Doing Business

2. Market Dynamics

                2.1 Drivers

                2.2 Restraints

                2.3 Opportunities

3. Market Demand Analysis

                3.1 Socio-Economic Segmentation

                3.2 Demographic Strengths & Weaknesses

                3.3 Spending Patterns

                3.4 Target Market Identification

4. Market Size of Adjuvant Industry (USD millions)

                4.1 By Types of Inorganic Compounds

                4.2 By Bacterial Products

5. Market Entry

                5.1 Market Entry: The Strategy

                                5.1.1 Types of Entry Modes, by Market Entry Objectives

                                5.1.2 Competition Analysis

                                                5.1.2.1 Market Share

                                                5.1.2.2 Strategies Adopted, Recent Events 

                                5.1.3 Pricing Strategy

                                5.1.4 Supply Chain Analysis

                                                5.1.4.1 Trade (Import-Export Analysis)

                                                5.1.4.2 Distribution Network & Retail Analysis

                5.2 Market Entry: The Administration

                                5.2.1 How to Register a Company (Flowchart)

                                5.2.2 Registration Processes 

                                                5.2.2.1 Ministries Involved

                                                5.2.2.2 Criteria and Conditions

                                5.2.3 List of Forms & Documents

                                5.2.4 Product Control Guidelines specified by the Government

6. Sources

7. Disclaimer

Purchase Report

Our Clients Include View All

Looking to Customize Report?

Complete your payment details below

Shipping & Billing Information

Payment Information